Back to News
Market Impact: 0.25

Thinking Beyond U.S. Stocks? This Global ETF Provides Access to Worldwide Opportunities.

TSMASMLSAPAZNHSBCNVS
Artificial IntelligenceTechnology & InnovationInvestor Sentiment & PositioningMarket Technicals & FlowsEmerging MarketsTrade Policy & Supply ChainCompany Fundamentals
Thinking Beyond U.S. Stocks? This Global ETF Provides Access to Worldwide Opportunities.

U.S. equities have dramatically outperformed non-U.S. stocks (Dodge & Cox: >500% outperformance from 2010 through last year) and the S&P 500 has risen ~66% over the past three years, driven by AI-fueled mega-cap strength; however, U.S. valuations are near record highs while non-U.S. equities remain within historical norms. The Vanguard Total International Stock ETF (VXUS) offers exposure to over 8,400 non-U.S. names (top holdings include TSMC, Tencent, ASML, Alibaba, Samsung, Nestlé, Novartis), has gained ~24% year-to-date (outperforming the S&P 500 by ~10 percentage points), charges a 0.05% expense ratio and is positioned as a low-cost diversification vehicle should global equity leadership mean-revert from the U.S.

Analysis

Market structure: The recent VXUS outperformance (≈+24% YTD vs S&P 500 ≈+14% YTD) signals a rotation away from concentrated US mega-cap/AI exposure toward economically cyclicals, financials and non-US tech suppliers (TSM, ASML). Winners: semicap equipment and diversified international exporters; losers: overvalued US growth multiples and uncoupled EM domestic-consumption names. Expect relative share gains for capital-goods suppliers and banks if global capex and trade volumes rise 6–12 months out. Risk assessment: Tail risks include renewed China regulatory shocks, a China growth miss, Taiwan strait escalation (material for TSM, ASML), or a US Fed surprise that rekindles USD strength; any of these could trigger >15% drawdowns in VXUS over 1–3 months. Short-term (days–weeks) FX and liquidity gyrations matter; medium-term (3–12 months) fundamentals (PMIs, earnings) will re-price country allocations; long-term (>12 months) mean reversion of valuations could persist if US multiples contract by 10–30%. Hidden dependency: many international winners are exposed to semiconductor cycles and commodity price swings. Trade implications: Tactical overweight to broad non-US exposure (VXUS or regional ETFs) while hedging US mega-cap downside is favoured; concentrate direct longs on TSM and ASML for supply-chain scarcity and AI-related capex, and rotate into EU/UK banks (HSBC) and pharma (AZN, NVS) on pullbacks. Use pair trades to express relative view (long TSM/ASML vs short SPY or QQQ) and prefer options for risk-defined exposure (3–6 month structures). Contrarian angles: Consensus assumes durable US AI leadership — that underestimates critical non-US choke points (ASML lithography, TSM capacity) and may underprice international cash-flow resiliency and dividends. The move may be underdone on fundamentals but overdone on political/FX complacency; similar rotations (2016–2018 cyclical rebound) showed 20–30% reversals when geopolitical or Fed tightening arrived. Unintended consequence: rapid flows into VXUS can elevate local liquidity and increase tracking error during stress.